NAVITOR PHARMACEUTICALS
Navitor Pharmaceuticals is a developer of novel medicines designed to target specific nutrient-sensing proteins that selectively regulate mTORC1 activity to treat diseases. The company's medicines selectively modulate the activity of mTORC1, a master regulator of cell growth and metabolism, and unlock the therapeutic potential of the mTOR pathway by targeting the amino acid and other nutrient sensors that selectively regulate the activity of mTORC1, enabling healthcare practitioners to address a wide range of metabolic, neurodegenerative, autoimmune and musculoskeletal diseases. It was founded in 2009 and headquartered in Cambridge, Massachusetts.
NAVITOR PHARMACEUTICALS
Industry:
Biopharma Biotechnology Developer Platform Health Diagnostics Pharmaceutical
Founded:
2009-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.navitorpharma.com
Total Employee:
11+
Status:
Active
Contact:
781-538-6113
Email Addresses:
[email protected]
Total Funding:
98.17 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Allcyte
Allcyte is a biotech start-up focused on precision medicine and drug development in a patient-centric way using high-content imaging and AI
Anjarium Biosciences
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Ario Pharma
Ario Pharma is focused on the development of drugs for the treatment of respiratory indications.
Aushon BioSystems
Aushon BioSystems provides robust protein biomarker assay development, detection and analysis through multiplex immunoassay platform.
Avisa Pharma
Avisa Pharma provides a solution to test a virulent bacterial infection from strep pneumonia and viral lung infection.
BioMarin Pharmaceutical
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Cadence Health
Cadence, a pharma startup, aims to switch a birth control pill over-the-counter to create easy and affordable access to contraceptives.
Cambridge Nutraceuticals
Cambridge Nutraceuticals develops and markets supplements scientifically proven to deliver more of the good.
Cancer Targeting Systems
CTS aims to combine the imaging and treatment of cancer, enabling clinicians and patients to make clearer choices.
Cardax Pharma
Cardax Pharma offers small molecule therapies for unmet medical needs such as hepatitis, arthritis, cardiovascular diseases, and more.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Curileum Discovery Ltd
Curileum Discovery Ltd is a drug target discovery company in London targeting defective stem cells underpinning serious GI diseases
EIP Pharma
EIP Pharma Provides Healthcare Services.
Emerald Health Pharmaceuticals
EHP is a biotech company developing biotechnology and cannabinoids science and technology to treat incurable diseases.
F-Star Therapeutics
F-Star Therapeutics is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
Gemini Therapeutics
Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.
Grolltex, Inc.
Grolltex, the largest US producer of electronics grade graphene, is also designing and manufacturing graphene biosensors on plastic
HDT Bio
IMMUNE THERAPY FOR ALL: We’re transforming inventive immunotherapies for oncology and infectious disease.
Intabio
Intabio is a developer of a real-time protein analytics platform used to transform the development of biotherapeutic drug.
IntegenX
IntegenX designs, manufactures and markets automation systems facilitating reliable micro sample preparation and analysis.
Laboratoire PhytoChemia inc
PhytoChemia inc is an expert in plant chemistry and offers standardization and chemical quality control solutions for plant based products.
LNC Therapeutics
LNC Therapeutics is developing gut microbiota directed drugs to target obesity and associated cardiometabolic diseases.
LB Pharmaceuticals
LB Pharmaceuticals specializes in developing a treatment for schizophrenia.
Manus Bio
Manus Bio makes nature accessible and affordable for a growing society.
MitrAssist
MitrAssist offers a minimally invasive approach to mitral regurgitation treatment.
MultiplexDX Inc.
Developing products for precision medicine: affordable, reliable, specific, quantifiable, and accurate precision diagnostic technology.
Navidea Biopharmaceuticals
Navidea develops precision immunodiagnostic agents and immunotherapeutics for patients with cancer, autoimmune, and infectious diseases.
Nivagen Pharmaceuticals, Inc.
Nivagen engages in the development, acquisition, and sales of generic prescription drugs and over the counter products.
Nomic Bio
Nomic develops a proteomic technology platform designed to understand, detect, and treat diseases with DNA nanotechnology.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Oxford Nanopore Technologies
Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
Pharma Two B
Pharma Two B develops clinical products based on approved drugs, focusing on fixed-dose-combinations of two or more drugs for PD and cancer.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
PLx Pharma
PLx Pharma develops and commercializes non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
PyTorch
PyTorch is a deep learning framework optimized for achieving state of the art results in research, regardless of resource constraints.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Reiley Pharmaceuticals
Reiley Pharmaceuticals is a developer of biopharmaceutical products designed to treat pain, cancer and infectious diseases.
SanaRx Biotherapeutics
SanaRx Biotherapeutics is designed to improve detection, visualization and treatment of 3 rare diseases.
Savara Pharmaceuticals
Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection in cystic fibrosis.
Skipping Rocks Lab
Skipping Rocks Lab develops natural and biodegradable packaging for liquids made from seaweed extract.
Stellar Biotechnologies
Stellar Biotechnologies develops treatments for dermatological and anorectal diseases
TauRx Pharmaceuticals
TauRx Pharmaceuticals is a life sciences company developing drugs and diagnostics for neurodegenerative diseases.
UAS Laboratories
UAS Labs is a global leader in probiotic innovation
Wright Avenue Partners
Wright Avenue Partners deliver Functional Service Provider (FSP) and specialty resourcing solutions.
Current Advisors List
Current Employees Featured
Founder
Investors List
SR One
SR One investment in Series B - Navitor Pharmaceuticals
Sanofi Ventures
Sanofi Ventures investment in Series B - Navitor Pharmaceuticals
Remeditex Ventures
Remeditex Ventures investment in Series B - Navitor Pharmaceuticals
Atlas Venture
Atlas Venture investment in Series B - Navitor Pharmaceuticals
Polaris Partners
Polaris Partners investment in Series B - Navitor Pharmaceuticals
Brace Pharma
Brace Pharma investment in Series B - Navitor Pharmaceuticals
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series B - Navitor Pharmaceuticals
Atlas Venture
Atlas Venture investment in Series A - Navitor Pharmaceuticals
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series A - Navitor Pharmaceuticals
The Longevity Fund
The Longevity Fund investment in Series A - Navitor Pharmaceuticals
Official Site Inspections
http://www.navitorpharma.com
- Host name: vux.netsolhost.com
- IP address: 206.188.192.134
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Navitor Pharmaceuticals"
Navitor Pharmaceuticals - workinbiotech.com
Navitor Pharmaceuticals is a biopharmaceutical company delving into the world of cellular metabolism signaling pathways. Their proprietary drug discovery platform focuses on …See details»
Navitor Pharmaceuticals - LinkedIn
Navitor Pharmaceuticals, Inc., is a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling pathways. The company’s proprietary drug discovery platform targets...See details»
Navitor Pharmaceuticals - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 781-538-6113 Navitor Pharmaceuticals is a developer of novel medicines designed to target specific nutrient-sensing …See details»
Navitor Pharmaceuticals - PitchBook
Description. Operator of a biopharmaceutical company designed to target specific nutrient-sensing proteins.See details»
Navitor Pharmaceuticals | VentureRadar
Website: http://www.navitorpharma.com. Develops mTORC1-targeted therapeutics for longer, healthier lives using proprietary platform enabling specific modulation of ...See details»
Navitor Pharmaceuticals Inc - Company Profile and News
Company profile page for Navitor Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Navitor Pharmaceuticals - Craft
Navitor Pharmaceuticals, Inc., is a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling pathways. The company’s proprietary drug discovery …See details»
Who's Who in Gerontology: Navitor Pharmaceuticals - Senescence
Contact Details. Address. 1030 Massachusetts Avenue, Suite 410, Cambridge, MA 02138, USA. E-mail (# = @) partnering#navitorpharma.com. Website. http://www.navitorpharma.com/ More …See details»
Navitor Pharmaceuticals - Contacts, Employees, Board Members, …
Navitor Pharmaceuticals. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 8. Number of Board Member and …See details»
Navitor Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ
Apr 5, 2022 · Navitor Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Navitor Pharmaceuticals | Company | Mindmaps
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.See details»
Navitor Pharmaceuticals Company Overview, Contact Details
Apr 21, 2020 · Sep 11, 2019 | www.navitorpharma.com Navitor, Inc. is developing first-in-class selective modulators of mTORC1. Navitor’s proprietary drug discovery platform is designed to …See details»
Navitor Pharmaceuticals - BioSpace
Nov 2, 2018 · Biotech companies continue to adjust their leadership ranks and strengthen the members of their organization representing and overseeing the companies. Here is a look at …See details»
Navitor Pharmaceuticals CEO and Key Executive Team | Craft.co
Navitor Pharmaceuticals's President and Chief Executive Officer, Director is Thomas E. Hughes. Other executives include Alan Crane, Co-Founder and Chairman of the Board; John Creecy, …See details»
Overview, News & Similar companies - ZoomInfo.com
Navitor Pharmaceuticals contact info: Phone number: (857) 285-4300 Website: www.navitorpharma.com What does Navitor Pharmaceuticals do? Navitor Pharmaceuticals, …See details»
Marek Kabat, Ph.D., D.Sc. - Director Process Chemistry at ... - The Org
Contact. Marek Kabat, Ph.D., D.Sc. has extensive work experience in the pharmaceutical and biotechnology industries. Marek is currently serving as the Director of Process Chemistry at …See details»
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Dec 18, 2015 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Navitor Pharmaceuticals, Inc., a biopharmaceutical company developing novel medicines targeting the activation of mTORC1, …See details»
Navitor Pharmaceuticals Commences Phase 1 Clinical Evaluation …
Pharmaceuticals, Inc. is the leader in the development of mTORC1-targeted therapeutics designed to help patients live longer and healthier lives. The Company’s proprietary platform …See details»
Navitor Pharmaceuticals, Inc. | Insights
Feb 9, 2022 · Leading immuno-oncology pioneer, Daniel Chen , has been appointed chief medical officer, a newly created position, at Mountain View, CA-based IGM Biosciences , to lead its …See details»
Navitor Pharmaceuticals Launches with $23.5 Million Series A …
CAMBRIDGE, Mass., Jun 19, 2014 - Navitor Pharmaceuticals, Inc. , a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling, today announced …See details»